Home » Topics » Regulatory

Regulatory
RSS

FDA approves Opsumit for PAH

Oct. 21, 2013

FDA approves Novoeight for use in adults and children with hemophilia A

Oct. 17, 2013

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013

FDA approves Cimzia for treatment of active psoriatic arthritis

Oct. 1, 2013

Simeprevir obtains first approval in Japan

Sep. 27, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...